Cargando…
Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
BACKGROUND: Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier initiation is not yet described. OBJECTIVES: We assessed the early neurodevelopment of HIV+ infants who started ART withi...
Autores principales: | Laughton, Barbara, Naidoo, Shalena, Dobbels, Els F.M.T., Boivin, Michael J., van Rensburg, Anita Janse, Glashoff, Richard H., van Zyl, Gert U., Kruger, Mariana, Cotton, Mark F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852492/ https://www.ncbi.nlm.nih.gov/pubmed/31745434 http://dx.doi.org/10.4102/sajhivmed.v20i1.1008 |
Ejemplares similares
-
Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
por: Laughton, Barbara, et al.
Publicado: (2018) -
HIV‐1 DNA decay is faster in children who initiate ART shortly after birth than later
por: Veldsman, Kirsten A, et al.
Publicado: (2019) -
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
por: Hainline, Clotilde, et al.
Publicado: (2011) -
Approach to the management of paediatric HIV spontaneous controllers
por: Zuidewind, Peter, et al.
Publicado: (2022) -
Neurodevelopment in perinatally HIV-infected children: a concern for adolescence
por: Laughton, Barbara, et al.
Publicado: (2013)